Monitor for further selling or commentary around next earnings — current activity is routine for executives managing equity compensation, but continued outflows could signal caution.
Price Chart
Executive Summary
CEO Claire Mazumdar and President Ryan Cohlhepp of Bicara Therapeutics (BCAX) exercised stock options and sold shares in a coordinated cluster over four days, generating $302,422 in open-market sales. The transactions represent modest insider selling following derivative exercises, with total proceeds under 0.1% of the company's $1.0B market cap.
Key Financial Metrics
Key Facts
- CEO Claire Mazumdar sold 15,000 shares for $282,366 across three days (March 18–20), following full option exercises.
- President Ryan Cohlhepp sold 8,000 shares for $157,257 on March 16 after exercising options.
- All sales were open-market transactions (code S) preceded by derivative exercises (code M).
- Total cash proceeds from selling activity: $302,422 (CEO: $282,366, President: $157,257).
- No open-market purchases or grants; all activity is consistent with pre-planned option monetization.
Financial Impact
$302,422 in insider selling, representing 0.03% of BCAX's $1.0B market cap
Risk Factors
- Perception of insider pessimism if no offsetting buybacks or positive news follow.
- Potential downward pressure if additional executives sell in coming weeks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (12 trades, 7d window) | cluster-BCAX-1774040615039 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | 8-K | $24.73 $19.78 | ▼ −20.02% | ▼ −20.24% | $18.25 (−26.18%) |
Aug 14, 2026 7w ago | Press Release | $24.28 $23.20 | ▼ −4.45% | ▼ −2.46% | $18.25 (−24.81%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $18.25 (−22.75%) |
Aug 12, 2026 7w ago | Insider Cluster | $23.63 $22.81 | ▼ −3.47% | ▼ −1.72% | $18.25 (−22.75%) |
Aug 11, 2026 7w ago | 8-K | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $18.25 (−23.17%) |
Aug 11, 2026 7w ago | Press Release | $23.76 $23.64 | ▼ −0.51% | ▲ +0.55% | $18.25 (−23.17%) |
Jul 14, 2026 11w ago | Insider Cluster | $28.10 $23.76 | ▼ −15.44% | ▼ −17.94% | $18.25 (−35.04%) |
Jun 11, 2026 16w ago | Institutional Cluster | $21.28 $29.68 | ▼ −39.47% | ▼ −37.58% | $18.25 (+14.22%) |
May 26, 2026 18w ago | Insider Cluster | $21.58 $26.34 | ▲ +22.06% | ▲ +23.96% | $18.25 (−15.41%) |
May 11, 2026 20w ago | 8-K | $22.92 $20.56 | ▼ −10.30% | ▼ −9.99% | $18.25 (−20.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access